SCHEMBL3308104

SCHEMBL3308104

FC(F)(F)c1ccc(-c2ccc3scnc3c2)nc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 1/20 0.43
TRPV3 Q8NET8 1/20 0.39
MEN1 O00255 1/20 0.39
NPC1 O15118 1/20 0.39
POLB P06746 1/20 0.39
RAB9A P51151 1/20 0.39
KMT2A Q03164 1/20 0.39
KDM1A O60341 2/20 0.38
MAOB P27338 2/20 0.38
PIK3CD O00329 1/20 0.37
P2RX7 Q99572 1/20 0.37
FFAR1 O14842 1/20 0.36
ALOX5AP P20292 1/20 0.36
FEN1 P39748 1/20 0.36
NPSR1 Q6W5P4 2/20 0.36
CYP11B1 P15538 1/20 0.36
CYP11B2 P19099 1/20 0.36
CASP3 P42574 1/20 0.36
GCK P35557 1/20 0.36
RIPK2 O43353 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1851318 0.81 TRPV3 (0.44) TRPV3NPC1RAB9APIK3CDFFAR1
SCHEMBL3303277 0.80 RIPK2 (0.39) TRPV3MEN1NPC1POLBRAB9A
SCHEMBL1538312 0.80 NPC1 (0.47) MEN1NPC1POLBRAB9AKMT2A
SCHEMBL30375905 0.80 NPC1 (0.47) MEN1NPC1POLBRAB9AKMT2A
SCHEMBL13394460 0.78 DYRK1A (0.42) TRPV3MEN1NPC1POLBRAB9A
SCHEMBL30499479 0.77 KIF11 (0.40) KIF11MEN1NPC1POLBRAB9A
SCHEMBL3305165 0.77 CYP11B2 (0.47) MEN1NPC1POLBRAB9AKMT2A
Hydrochloric Acid SCHEMBL3304866 0.77 DYRK1A (0.41) TRPV3MEN1NPC1POLBRAB9A
SCHEMBL27344645 0.76 KIF11 (0.63) KIF11KMT2AKDM1AMAOBP2RX7
SCHEMBL13539289 0.75 NPC1 (0.48) TRPV3MEN1NPC1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8420052-B2 Imaging agents useful for identifying AD pathology SIEMENS MEDICAL SOLUTIONS USA, INC. (US) 2013-04-16 US disclosed
US-8420052-B2 Imaging agents useful for identifying AD pathology SIEMENS MEDICAL SOLUTIONS USA, INC. (US) 2013-04-16 US disclosed
US-8420052-B2 Imaging agents useful for identifying AD pathology SIEMENS MEDICAL SOLUTIONS USA, INC. (US) 2013-04-16 US disclosed
US-20100098634-A1 Imaging Agents Useful for Identifying AD Pathology SIEMENS MEDICAL SOLUTIONS USA, INC. 2010-04-22 US disclosed
US-20100098634-A1 Imaging Agents Useful for Identifying AD Pathology SIEMENS MEDICAL SOLUTIONS USA, INC. 2010-04-22 US disclosed
US-20100098634-A1 Imaging Agents Useful for Identifying AD Pathology SIEMENS MEDICAL SOLUTIONS USA, INC. 2010-04-22 US disclosed
WO-2010011964-A2 IMAGING AGENTS USEFUL FOR IDENTIFYING AD PATHOLOGY SIEMENS MEDICAL SOLUTIONS USA, INC. (US) 2010-01-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100098634-A1 Imaging Agents Useful for Identifying AD Pathology APP, APBA1, PYGB KIF11 4846/4885TRPV3 2013/4885MEN1 1127/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.